Certara, Inc.
NASDAQCertara heads into October with a striking divergence: the street just turned more cautious, yet short sellers have been quietly covering and options traders are the most bullish they have been all year. The most immediate catalyst is an analyst move landed this morning. UBS downgraded Certara to Neutral from Buy, keeping its $10 target unchanged. That puts one of the more…
CERT UBS analyst downgrades to Neutral from Buy, maintains $10 price target; stock up 4.9% weekly as short interest eases to 17.3% of float.
Snapshot as of 30 Sept 2026
Certara heads into October with a striking divergence: the street just turned more cautious, yet short sellers have been quietly covering and options traders are the most bullish they have been all year. The most…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CERT — free to start on ORTEX.
Sign up for free →Open CERT on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CERT data →